Please use this identifier to cite or link to this item:
http://nopr.niscpr.res.in/handle/123456789/62320Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kawle, Pravin R | - |
| dc.date.accessioned | 2023-07-20T09:13:42Z | - |
| dc.date.available | 2023-07-20T09:13:42Z | - |
| dc.date.issued | 2023-07 | - |
| dc.identifier.issn | 2583-1321 (Online); 0019-5103 (Print) | - |
| dc.identifier.uri | http://nopr.niscpr.res.in/handle/123456789/62320 | - |
| dc.description | 691-695 | en_US |
| dc.description.abstract | A new series of symmetric acridin-9-yl-bis-benzothiazol-2-yl-amines have been synthesized in good to excellent yields by intra-molecular cyclization of 1-acridin-9-yl-1-benzothiazol-2-yl-3-aryl thiourea and screened for their in vitro antitubercular activity against Mycobacterium tuberculosis by BACTEC radiometric method. The synthesis of new analogues bearing an acridine-linked chloro-substituted benzothiazole has demonstrated enhanced antituberculosis activity. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | NIScPR-CSIR,India | en_US |
| dc.source | IJC Vol.62(07) [July 2023] | en_US |
| dc.subject | Tuberculosis | en_US |
| dc.subject | Acridine | en_US |
| dc.subject | Benzothiazole | en_US |
| dc.title | Synthesis and antituberculosis action of symmetric acridin-9-yl-bisbenzothiazol- 2-yl-amines | en_US |
| dc.type | Article | en_US |
| dc.identifier.doi | https://doi.org/10.56042/ijc.v62i7.430 | en_US |
| Appears in Collections: | IJC Vol.62(07) [July 2023] | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| IJC 62 (07) 691-695.pdf | 799.6 kB | Adobe PDF | View/Open |
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.